Michael Elliot Shankman - Chief Financial Officer at Lexaria Bioscience Corp.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
LEXX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael Elliot Shankman since 26 May 2025

Holdings reported by Michael Elliot Shankman for Lexaria Bioscience Corp.

Form 4 holding Chief Financial Officer

Lexaria Bioscience Corp.

Security class
Stock Options
Shares / value
100,000
Estimated value
$122,000
Report date
15 May 2025
Price
$1.22
Ownership
Direct
Underlying class
Common Shares
Underlying amount
100,000

Transactions reported by Michael Elliot Shankman for Lexaria Bioscience Corp.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .